DOI QR코드

DOI QR Code

Change in Trend in Various Clinico-Pathological Factors and Treatment Profile of Breast Cancer Patients: a Tertiary Cancer Centre Experience

  • Shankar, Abhishek (Department of Radiation Oncology, Dr. B.R. Ambedkar Institute Rotary Cancer Hospital, Maulana Azad Medical College) ;
  • Roy, Shubham (Department of Paediatrics, VMMC & Safdarjung Hospital,Maulana Azad Medical College) ;
  • Rath, GK (Department of Radiation Oncology, Dr. B.R. Ambedkar Institute Rotary Cancer Hospital, Maulana Azad Medical College) ;
  • Kamal, Vineet Kumar (Department of Bio-statistics, Maulana Azad Medical College) ;
  • Bhandari, Menal (Department of Radiation Oncology, Dr. B.R. Ambedkar Institute Rotary Cancer Hospital, Maulana Azad Medical College) ;
  • Kulshrestha, Rashi (Department of Radiation Oncology, Maulana Azad Medical College) ;
  • Prasad, Neelam (Department of Obstetrics & Gynaecology, All India Institute of Medical Sciences) ;
  • Sachdev, Jaineet (Department of Radiation Oncology, Christian Medical College) ;
  • Jeyaraj, Pamela (Department of Radiation Oncology, Christian Medical College)
  • Published : 2016.08.01

Abstract

Background: Breast cancer is by far the most frequent cancer of women (23% of all cancers), ranking second overall when both sexes are considered together. Since there has been change in clinico-pathological factors and treatment profiles for breast cancer patients over the years, the present study to evaluate the change trends in India. Materials and Methods: A detailed analysis was carried out with respect to age, menopausal status, family history, disease stage, surgery performed, histopathology, hormone receptor status, and use of chemotherapy or hormonal therapy. Change in various clinico-pathological factors and treatments of breast cancer cases was recorded and analysed. Results: Mean age at presentation was found to be earlier in 2005-2006 compared with 1997-98 (p value: 0.046). More premenopausal women were diagnosed with breast cancer in 2005-2006 when this was compared with initial years of assessment (p value ${\leq}0.001$). When change in the receptor status was evaluated, we observed that there was a decrease in cases of ER and PR receptor positivity which was significant (p value: 0.007). Over the period of time, more f patients were not offered surgery initially in view of advanced disease when the two time periods were compared (p value: ${\leq}0.001$). There was a significant increase in patients who were initially offered neo-adjuvant chemotherapy in view of advanced disease at presentation (p value: ${\leq}0.001$). There was increasing number of patients who received palliative treatment for symptoms in 2005-2006 when compared to patients treated in 1997-98((p value: ${\leq}0.001$). Conclusions: Changes in mean age at presentation, premenopausal status, and stage at presentation have occurred over the years. More aggressive patterns of disease have become more common with early age at presentation and aggressive biological behaviour with receptor negative tumours.

Keywords

Breast cancer;clinico-pathological spectrum;change in trends

References

  1. Agarwal G, Pradeep PV, Aggarwal V, Yip CH, Cheung PS (2007). Spectrum of breast cancer in Asian women. World J Surg, 31, 1031-40. https://doi.org/10.1007/s00268-005-0585-9
  2. Afsharfard A, Mozaffar M, Orang E, et al (2013). Trends in epidemiology, clinical and histopathological characteristics of breast cancer in Iran: results of a 17 year study. Asian Pac J Cancer Prev, 14, 6905-11. https://doi.org/10.7314/APJCP.2013.14.11.6905
  3. Bray F, Carron P, Parkin D (2004). The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res, 6, 229-39. https://doi.org/10.1186/bcr932
  4. Chauhan A, Subba SH, Menezes RG, et al (2011). Younger women are affected by breast cancer in south india-a hospital-based descriptive study. Asian Pac J Cancer Prev, 12, 709-11.
  5. Ferlay J, Soerjomataram I, Ervik M, et al (2015). Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer, 136, 359-86. https://doi.org/10.1002/ijc.29210
  6. Freitas JR, Freitas NM, Curado MP, et al (2010). Incidence trend for breast cancer among young women in Goiania, Brazil. Sao Paulo Med J, 128, 81-4. https://doi.org/10.1590/S1516-31802010000200007
  7. Green M, Raina V (2008). Epidemiology, screening and diagnosis of breast cancer in the Asia-Pacific region: Current perspectives and important considerations. Asia Pac J Clin Oncol, 4, 5-13. https://doi.org/10.1111/j.1743-7563.2008.00191.x
  8. Harirchi I, Kolahdoozan S, Karbakhsh M, et al (2011). Twenty years of breast cancer in Iran: downstaging without a formal screening program. Ann Oncol, 22, 93-97. https://doi.org/10.1093/annonc/mdq303
  9. Howlader N, Noone AM, Krapcho M, et al (2013). SEER cancer statistics review, 1975-2011, national cancer institute. bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.
  10. Jemal A, Bray F, Center MM, Ferlay J, et al (2011). Global cancer statistics. Cancer J Clinicia, 61, 69-90. https://doi.org/10.3322/caac.20107
  11. Kakarala M, Rozek L, Cote M, Liyanage S, Brenner DE (2010). Breast cancer histology and receptor status characterization in Asian Indian and Pakistani women in the U.S.--a SEER analysis. BMC Cancer, 10, 191. https://doi.org/10.1186/1471-2407-10-191
  12. Kim Y, Yoo KY, Goodman MT (2015). Differences in incidence, mortality and survival of breast cancer by regions and countries in Asia and contributing factors. Asian Pac J Cancer Prev, 16, 2857-70. https://doi.org/10.7314/APJCP.2015.16.7.2857
  13. Lotfnezhad Afshar H, Ahmadi M, Roudbari M, Sadoughi F (2015). Prediction of breast cancer survival through knowledge discovery in databases. Glob J Health Sci, 7, 392-8.
  14. Mathers C D, Loncar D, (2006). Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med, 3, 442. https://doi.org/10.1371/journal.pmed.0030442
  15. Memon ZA, Qurrat-ul-Ain, Khan R ,Raza N, Noor T (2015). Clinical presentation and frequency of risk factors in patients with breast carcinoma in Pakistan. Asian Pac J Cancer Prev, 16, 7467-72. https://doi.org/10.7314/APJCP.2015.16.17.7467
  16. Miller A (2010). Screening for breast cancer in eastern mediterranean region. East Mediterranean Health J, 16, 10. https://doi.org/10.26719/2010.16.1.10
  17. Montazeri A (2008). Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007. J Exp Clin Cancer Res, 27, 32. https://doi.org/10.1186/1756-9966-27-32
  18. Mousavi-Jarrrahi S H, Kasaeian A, Mansori K (2013). Addressing the younger age at onset in breast cancer patients in Asia: an age-period-cohort analysis of fifty years of quality data from the international agency for research on cancer. ISRN Oncol, 2013, 429862.
  19. National Breast Cancer coalition, NBCC. (2011). Ending breast cancer: a baseline progress report, breast cancer deadline 2020. Washington.
  20. Niu HY, Niu CY, Wang JH, et al (2013). Health-related quality of life in women with breast cancer: a literature-based review of psychometric properties of breast cancer-specific measures. Asian Pac J Cancer Prev, 15, 3533-6.
  21. Oran ES, Yankol Y, Soybir GR, et al (2014). Distinct postsurgical management in young and elderly breast cancer patients results in equal survival rates. Asian Pac J Cancer Prev, 15, 7843-7. https://doi.org/10.7314/APJCP.2014.15.18.7843
  22. Pakseresht S, Ingle GK, Bahadur AK, Ramteke VK, Singh MM, Garg S, et al (2009). Risk factors with breast cancer among women in Delhi. Indian J Cancer, 46, 132-8. https://doi.org/10.4103/0019-509X.49151
  23. Sandhu DS, Sandhu S, Karwasra RK, Marwah S (2010). Profile of breast cancer patients at a tertiary care hospital in north India. Indian J Cancer, 47, 16-22. https://doi.org/10.4103/0019-509X.58853
  24. Saxena S, Rekhi B, Bansal A, Bagga A, Chintamani, Murthy NS (2005). Clinico-morphological patterns of breast cancer including family history in a New Delhi hospital, India--A cross-sectional study. World J Surg Oncol, 3, 67. https://doi.org/10.1186/1477-7819-3-67
  25. Shankar A, Roy S, Rath GK, Julka PK, Kamal VK et al. (2015). Aromatase inhibition and capecitabine combination as 1st or 2nd line treatment for metastatic breast cancer - a retrospective analysis. Asian Pac J Cancer Prev, 16, 6359-64. https://doi.org/10.7314/APJCP.2015.16.15.6359
  26. Surakasula A, Nagarjunapu GC, Raghavaiah KV (2014). A comparative study of pre- and post-menopausal breast cancer: Risk factors, presentation, characteristics and management. J Res Pharm Pract, 3, 12-18. https://doi.org/10.4103/2279-042X.132704
  27. Takalkar UV, Asegaonkar SB , Kulkarni U , Kodlikeri PR , Kulkarni U , Saraf M , Advani S (2016). Clinicopathological profile of breast cancer patients at a tertiary care hospital in marathwada region of Westen India. Asian Pac J Cancer Prev, 17, 2195-98. https://doi.org/10.7314/APJCP.2016.17.4.2195
  28. Wani SQ, Khan T, Wani SY, et al (2012). Clinicoepidemiological analysis of female breast cancer patients in Kashmir. J Cancer Res Ther, 8, 389-93. https://doi.org/10.4103/0973-1482.103518